Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.35 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5109283 | 0.77 | TGFBR1 (0.32) | — | |
| SCHEMBL11501156 | 0.77 | FAAH (0.33) | ALDH1A1MAPK1 | |
| SCHEMBL10489511 | 0.74 | ALDH1A1 (0.39) | ALDH1A1CYP3A4CYP2C9CYP2C19ZDHHC20 | |
| SCHEMBL8765522 | 0.73 | ALDH1A1 (0.41) | ALDH1A1CYP3A4CYP2C9CYP2C19ZDHHC20 | |
| SCHEMBL525540 | 0.71 | ALDH1A1 (0.49) | ALDH1A1MEN1KMT2ATSHRMAPK1 | |
| SCHEMBL9398270 | 0.71 | ALDH1A1 (0.42) | ALDH1A1CYP3A4CYP2C9CYP2C19ZDHHC20 | |
| SCHEMBL4906709 | 0.71 | KMT2A (0.53) | ALDH1A1CYP3A4CYP2C9CYP2C19ZDHHC20 | |
| SCHEMBL9766457 | 0.69 | ZDHHC20 (0.40) | ALDH1A1CYP3A4CYP2C9CYP2C19ZDHHC20 | |
| SCHEMBL8764635 | 0.68 | ALDH1A1 (0.40) | ALDH1A1CYP3A4CYP2C9CYP2C19ZDHHC20 | |
| SCHEMBL6333703 | 0.68 | ALDH1A1 (0.40) | ALDH1A1CYP3A4CYP2C9CYP2C19ZDHHC20 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7405188-B2 | Polymeric gel system and compositions for treating keratin substrates containing same | WSP CHEMICALS & TECHNOLOGY, LLC (US) | 2008-07-29 | — | — | US | disclosed |
| US-20050074417-A1 | Polymeric gel system and compositions for treating keratin substrates containing same | WSP CHEMICALS & TECHNOLOGY, LLC (US) | 2005-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050074417-A1 | Polymeric gel system and compositions for treating keratin substrates containing same | KRT18, CUTA, S100A10 | ALDH1A1 2189/4885CYP3A4 4259/4885CYP2C9 3902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.